Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSIF.L Regulatory News (SSIF)

  • There is currently no data for SSIF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

25 Sep 2015 16:49

RNS Number : 2932A
GLI Alternative Finance PLC
25 September 2015
 



 
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

GLI Alternative Finance Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Morgan Stanley

(Institutional Securities Group and Global Wealth Management)

4. Full name of shareholder(s)  (if different from 3.):iv

Morgan Stanley & Co. International plc

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

23/09/2015

6. Date on which issuer notified:

25/09/2015

7. Threshold(s) that is/are crossed orreached: vi, vii

3%,4%,5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

 

GB00BYMK5S87

 

Below 3%

 

 

Below 3%

 

3,000,000

3,000,000

 

 

5.69%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,000,000

5.69%

 

 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

Morgan Stanley & Co. International plc, 25 Cabot Square, Canary Wharf, London E14 4QA is a direct holder of  3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley Investments (UK)

 

Morgan Stanley Investments (UK), 20 Bank Street, Canary Wharf, London E14 4AD is an indirect holder of 3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley UK Group

 

Morgan Stanley UK Group, 25 Cabot Square, Canary Wharf, London E14 4QA is an indirect holder of 3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley Group (Europe)

 

Morgan Stanley Group (Europe), 20 Bank Street, Canary Wharf, London E14 4AD is an indirect holder 3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley International Limited

 

Morgan Stanley International Limited, 25 Cabot Square, Canary Wharf, London E14 4QA is an indirect holder of 3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley International Holdings Inc.

 

Morgan Stanley International Holdings Inc, c/o The Corporation Trust Company, Corporation Trust Centre, 1209 Orange Street, Wilmington, Delaware DE19801, USA is an indirect holder of 3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley.

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

 

 

14. Contact name:

Craig Horsley

15. Contact telephone number:

0141 245 7736

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUVSVRVNAKUAR
Date   Source Headline
2nd Aug 20238:19 amRNSDirector/PDMR Shareholding
1st Aug 202310:59 amRNSDirector/PDMR Shareholding
27th Jul 202312:00 pmRNSHolding(s) in Company
27th Jul 20239:45 amRNSDirector/PDMR Shareholding
25th Jul 202312:54 pmRNSNet Asset Value(s)
29th Jun 20237:00 amRNSB Share Scheme and Delisting
23rd Jun 20237:00 amRNSNet Asset Value(s)
30th May 20237:00 amRNSNet Asset Value(s)
22nd May 20234:45 pmRNSHolding(s) in Company
27th Apr 20237:00 amRNSNet Asset Value(s)
29th Mar 20234:35 pmRNSPrice Monitoring Extension
22nd Mar 20237:00 amRNSNet Asset Value(s)
16th Mar 20232:05 pmRNSSecond Price Monitoring Extn
16th Mar 20232:00 pmRNSPrice Monitoring Extension
16th Mar 20237:00 amRNSHalf-year Report
15th Mar 202310:45 amRNSCancellation of Capital Redemption Reserve
13th Mar 20232:05 pmRNSSecond Price Monitoring Extn
13th Mar 20232:00 pmRNSPrice Monitoring Extension
8th Mar 20232:05 pmRNSSecond Price Monitoring Extn
8th Mar 20232:00 pmRNSPrice Monitoring Extension
1st Mar 20237:00 amRNSNet Asset Value(s)
30th Jan 20239:21 amRNSNet Asset Value(s)
29th Dec 20228:18 amRNSNet Asset Value(s)
15th Dec 20223:51 pmRNSResult of AGM and GM
6th Dec 20225:39 pmRNSHolding(s) in Company
29th Nov 20228:36 amRNSNet Asset Value(s)
23rd Nov 20225:27 pmRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSPublication of a circular
15th Nov 20227:00 amRNSNet Asset Value(s)
9th Nov 20221:24 pmRNSB Share Scheme
27th Sep 20228:48 amRNSNet Asset Value(s)
8th Sep 20224:00 pmRNSHolding(s) in Company
8th Sep 202210:00 amRNSAnnual Financial Report
2nd Sep 202212:00 pmRNSDividend Declaration
25th Aug 202210:00 amRNSNet Asset Value(s)
22nd Jul 20229:30 amRNSNet Asset Value(s)
11th Jul 20222:06 pmRNSSecond Price Monitoring Extn
11th Jul 20222:00 pmRNSPrice Monitoring Extension
11th Jul 202211:05 amRNSSecond Price Monitoring Extn
11th Jul 202211:00 amRNSPrice Monitoring Extension
29th Jun 20229:00 amRNSNet Asset Value(s)
6th Jun 20224:40 pmRNSSecond Price Monitoring Extn
6th Jun 20224:35 pmRNSPrice Monitoring Extension
6th Jun 20229:06 amRNSSecond Price Monitoring Extn
6th Jun 20229:00 amRNSPrice Monitoring Extension
26th May 20223:30 pmRNSB Share Scheme - Amendment
25th May 20224:53 pmRNSB Share Scheme
25th May 20229:00 amRNSNet Asset Value(s)
5th May 202212:00 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.